- Home
- ATOS vs KFFB Comparison
ATOS vs KFFB Comparison
Compare ATOS & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATOS | KFFB |
|---|---|---|
| Founded | 2009 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2M | 38.7M |
| IPO Year | 2010 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ATOS | KFFB |
|---|---|---|
| Price | $2.28 | $5.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 133.7K | 4.6K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 109.52 |
| EPS | N/A | ★ 0.15 |
| Revenue | $1,758.00 | ★ $15,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.53 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.53 | $2.96 |
| 52 Week High | $7.56 | $5.48 |
Technical Indicators
Market Signals| Indicator | ATOS | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 39.28 | 57.43 |
| Support Level | $0.58 | $4.26 |
| Resistance Level | $2.60 | $5.48 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 26.83 | 58.90 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.